| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Fabing HD |
New blocking agent against the development of LSD-25 psychosis. |
Science |
1955 |
| Fabing HD |
Frenquel, a blocking agent against experimental LSD-25 and mescaline p... |
Neurology |
1955 |
| Fabing HD |
Experimental compound MER-17 (Frenquel): A new blocking agent against ... |
Psychiatr. Res. Rep. |
1955 |
| Tonini G, Montanari C |
Effects of Experimentally Induced Psychoses on Artistic Expression |
Confinia neurol. |
1955 |
| Fabing HD, Hawkins JR |
Intravenous bufotenine injection in the human being |
Science |
1956 |
| Cattell JP |
Use of drugs in psychodynamic investigations. |
Experimental psychop... |
1957 |
| Freedman DX, Aghajanian G... |
Time parameters in acute tolerance, cross tolerance, and antagonism to... |
Federation Proc. |
1959 |
| Mahler DJ, Humoller FL |
Effect of lysergic acid diethylamide and bufotenine on performance of ... |
Proc. Soc. exper. Bi... |
1959 |
| Vojtechovsky M, Grof S |
Podobnosti a rozdíly mezi esperimentální psychózou po LSD-25 a po mezk... |
Csl. Psychiat. |
1960 |
| Higginbottam J, Melton B |
Some new experiences with L.S.D |
Nursing Mirror |
1961 |
| Ketchum JS, Aghajanian GK... |
THE HUMAN ASSESSMENT OF EA 1729 [LSD] AND EA 3528 BY THE INHALATION RO... |
CHEMICAL RESEARCH AN... |
1964 |
| Aghajanian GK, Bing OHL |
Persistence of lysergic acid diethylamide in the plasma of human subje... |
Clin. Pharmacol. The... |
1964 |
| Kusel H |
Ayahuasca Drinkers Among the Chama Indians of Northeast Peru |
The Psychedelic Revi... |
1965 |
| |
Clinical value of LSD questioned; physical damage reported |
Journal of American ... |
1967 |
| |
Dangers of LSD |
Lancet |
1967 |
| Wagner JG, Aghajanian GK,... |
Correlation of performance test scores with "tissue concentration" of ... |
Clin. Pharmacol.Ther... |
1968 |
| Ketchum JS |
Detection of LSD |
Amer J Psychiat |
1969 |
| Bebbington A, Brimblecomb... |
Actions of some toxic substances (psychotomimetics) on the central ner... |
Brit. Med. Bull. |
1969 |
| Witt PN |
Drugs alter web-building of spiders: a review and evaluation. |
Behav Sci. |
1971 |
| Friedhoff AJ, Schweitzer ... |
Biosynthesis of mescaline and N-acetylmescaline by mammalian liver |
Nature |
1972 |
| Barr HL, Langs RJ, Holt R... |
LSD : Personality And Experience |
|
1972 |
| Sadoff RL |
LSD, Alcohol, and Homicide. |
J.A m.Med.Assoc. |
1973 |
| Cooper PD |
Beta-chloroethylamines related to mescaline |
J Med Chem |
1973 |
| Jarvik JF, Yen FS, Dahlbe... |
Chromosome Examinations After Medically Administered Lysergic Acid Die... |
Dis Nerv Syst |
1974 |
| Matsuyama SS, Jarvik LF |
Cytogenetic Effects of Psychoactive Drugs |
Mod.Probl.Pharmacops... |
1975 |
| Ananth J |
Congenital malformations with psychopharmacologic agents |
Comprehensive Psychi... |
1975 |
| Krsiak M |
Timid Singly-housed Mice: Their Value In Prediction Of Psychotropic Ac... |
Brit. J. Pharmacol. |
1975 |
| Paul SM, Halaris AE, Free... |
Rat brain aryl acylamidase: stereospecific inhibition by LSD and serot... |
J. Neurochem. |
1976 |
| Rosengarten H, Friedhoff ... |
A review of recent studies of the biosynthesis and excretion of halluc... |
Schizophr Bull |
1976 |
| Pollock, S.H. |
Book Review: Growing Wild Mushrooms by B. Harris |
Journal of Psychoact... |
1976 |
| Follas WD, Cassady JM, Mc... |
β-phenethylamines from the cactus genus lobivia' |
Phytochemistry |
1977 |
| Kleinman JE, Gillin JC, W... |
A comparison of the phenomenology of hallucinogens and schizophrenia f... |
Schizophr Bull |
1977 |
| Green JP, Weinstein H, Ma... |
Defining the Histamine H2- Receptor in Brain: The Interaction With LSD |
QUASAR. Quantitative... |
1978 |
| Ruck CA, Bigwood J, Stapl... |
Entheogens |
J Psychedelic Drugs |
1979 |
| Krsiak M |
Effects of Drugs on Behaviour of Aggressive Mice |
Brit.J.Pharmacol. |
1979 |
| Sovilla JY, Magistretti P... |
Potentiation of Apomorphine-Induced Climbing Behaviour in Mice by d-LS... |
Progr.Neuro-Psychoph... |
1979 |
| Sovilla JY, Schorderet M |
Potentiation of apomorphine-induced climbing in mice by d-LSD |
Experientia |
1979 |
| Schorderet M, Sovilla JY,... |
New Findings Related To A Possible Interaction Of Ergolines And Ergope... |
Progress in Neuro-Ps... |
1980 |
| Kenyon CN, Melera A |
Use of the Direct Liquid Inlet LC/MS System for the Analysis of Comple... |
J.Chromatog.Sci. |
1980 |
| Nielsen EB, Nielsen M, El... |
Decreased Spiroperidol And LSD Binding In Rat Brain After Continuous A... |
European Journal of ... |
1980 |
| Francčs H, Lecrubier Y, P... |
Evidence for the role of noradrenaline in some effects of quipazine |
Psychopharmacology (... |
1980 |
| Crisp T, Stafinsky JL, Bo... |
The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA... |
Pharmacol Biochem Be... |
1989 |
| Paulus MP, Geyer MA |
A temporal and spatial scaling hypothesis for the behavioral effects o... |
Psychopharmacology (... |
1991 |
| McGuire P, Fahy T |
Flashbacks following MDMA |
Br J Psychiatry |
1992 |
| Emerson TS, Cisek JE |
Methcathinone: a Russian designer amphetamine infiltrates the rural mi... |
Ann Emerg Med |
1993 |
| Johnson EJ, Emche SD |
Variation of Alkaloid Content in Erythroxylum coca Leaves from Leaf Bu... |
Annals of Botany |
1994 |
| Drewnowski A, Krahn DD, D... |
Naloxone, an opiate blocker, reduces the consumption of sweet high-fat... |
Am J Clin Nutr |
1995 |
| Webb E, Ashton CH, Kelly ... |
Alcohol and drug use in UK university students |
Lancet |
1996 |
| Sabol KE, Lew R, Richards... |
Methylenedioxymethamphetamine-induced serotonin deficits are followed ... |
J Pharmacol Exp Ther |
1996 |
| Schifano F, Di Furia L, F... |
MDMA ('ecstasy') consumption in the context of polydrug abuse: a repor... |
Drug Alcohol Depend |
1998 |
| Bingham C, Beaman M, Nich... |
Necrotizing renal vasculopathy resulting in chronic renal failure afte... |
Nephrol Dial Transpl... |
1998 |
| Stolaroff MJ |
Are Psychedelics Useful in the Practice of Buddhism? |
Journal of Humanisti... |
1999 |
| Topp L, Hando J, Dillon P... |
Ecstasy use in Australia: patterns of use and associated harm |
Drug Alcohol Depend |
1999 |
| Rochester JA, Kirchner JT |
Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, ... |
J Am Board Fam Pract |
1999 |
| Monks TJ, Ghersi-Egea JF,... |
Symposium overview: the role of glutathione in neuroprotection and neu... |
Toxicol Sci |
1999 |
| Hammersley R, Ditton J, S... |
Patterns of ecstasy use by drug users |
British Journal of C... |
1999 |
| McCann UD, Eligulashvili ... |
(+/-)3,4-Methylenedioxymethamphetamine (`Ecstasy')-Induced Serotonin N... |
Neuropsychobiology |
2000 |
| Doblin RE |
Regulation of the Medical Use of Psychedelics and Marijuana |
Dissertation |
2000 |
| Anderson C |
Water intake probed in death |
Boulder Daily Camera |
2001 |
| Mendelson J |
Dextromethorphan and Ecstasy Pills (reply) |
JAMA |
2001 |
| Hansen D, Maycock B, Lowe... |
'Weddings, parties, anything…', a qualitative analysis of ecstasy use ... |
International Journa... |
2001 |
| Braff, DL, Geyer, MA and ... |
Human studies of prepulse inhibition of startle: normal subjects, pati... |
Psychopharmacology |
2001 |
| Ho E, Karimi-Tabesh L, Ko... |
Characteristics of pregnant women who use Ecstasy (3, 4- methylenediox... |
Neurotoxicol Teratol |
2001 |
| Kraemer T, Maurer HH |
Toxicokinetics of amphetamines: metabolism and toxicokinetic data of d... |
Ther Drug Monit |
2002 |
| Strote J |
Increasing MDMA use among college students: results of a national surv... |
J Adolesc Health |
2002 |
| Gesi M, Lenzi P, Soldani ... |
Morphological effects in the mouse myocardium after methylenedioxymeth... |
Anat Rec |
2002 |
| Ellison G |
Neural degeneration following chronic stimulant abuse reveals a weak l... |
Eur Neuropsychopharm... |
2002 |
| Badon LA, Hicks A, Lord K... |
Changes in Cardiovascular Responsiveness and Cardiotoxicity Elicited d... |
J Pharmacol Exp Ther |
2002 |
| Gesi M, Soldani P, Lenzi ... |
Ecstasy during Loud Noise Exposure Induces Dramatic Ultrastructural Ch... |
Pharmacol Toxicol |
2002 |
| Baggott M |
Preventing problems in ecstasy users; Reduce use to reduce harm |
J Psychoactive Drugs |
2002 |
| Bellis MA, Hughes K, Lowe... |
Healthy nightclubs and recreational substance use. From a harm minimis... |
Addict Behav |
2002 |
| Kish SJ |
What Is the Evidence That Ecstasy (MDMA) Can Cause Parkinson’s Disease... |
Movement Disorders |
2003 |
| Boyd CJ, McCabe SE, d'Arc... |
Ecstasy use among college undergraduates: gender, race and sexual iden... |
J Subst Abuse Treat |
2003 |
| Swanston HY, Plunkett AM,... |
Nine years after child sexual abuse |
Child Abuse Negl |
2003 |
| Bond AJ, Verheyden SL, Wi... |
Angry cognitive bias, trait aggression and impulsivity in substance us... |
Psychopharmacology (... |
2003 |
| Underwood B, Fox K, Nixon... |
Alcohol and drug use among vocational dental practitioners |
Br Dent J |
2003 |
| Turner C, Russell A, Brow... |
Prevalence of illicit drug use in young Australian women, patterns of ... |
Addiction |
2003 |
| Green AR, Sanchez V, O\'S... |
Effect of ambient temperature and a prior neurotoxic dose of 3,4-methy... |
Psychopharmacology (... |
2004 |
| Schifano F |
A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities |
Psychopharmacology (... |
2004 |
| Parrott AC |
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetam... |
J Psychopharmacology |
2005 |
| Meredith EJ, Holder MJ, C... |
The serotonin transporter (SLC6A4) is present in B-cell clones of dive... |
FASEB J |
2005 |
| Staack RF, Maurer HH |
Metabolism of designer drugs of abuse |
Curr Drug Metab |
2005 |
| Meredith EJ, Holder MJ, C... |
The serotonin transporter (SLC6A4) is present in B-cell clones of dive... |
FASEB J |
2005 |
| Leigh J, Bowen S, Marlatt... |
Spirituality, mindfulness and substance abuse |
Addict Behav |
2005 |
| Hussain MZ, Waheed W, Hus... |
Intravenous quetiapine abuse |
Am J Psychiatry |
2005 |
| Piper BJ, Vu HL, Safain M... |
Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure ... |
J Pharmacol Exp Ther |
2006 |
| Rasmussen N |
Making the first anti-depressant: amphetamine in American medicine, 19... |
J Hist Med Allied Sc... |
2006 |
| Kalra BS |
Cytochrome P450 enzyme isoforms and their therapeutic implications: An... |
Indian J Med Sci |
2007 |
| Wiegand TJ, Smollin CG. |
Ingestion of Mescal Beans (Sophora secundiflora) Causing Agitation in ... |
Clin Toxicol. |
2007 |
| Silins E, Copeland J, Dil... |
Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use o... |
Aust N Z J Psychiatr... |
2007 |
| Chyka PA, Erdman AR, Mano... |
Dextromethorphan poisoning: an evidence-based consensus guideline for ... |
Clin Toxicol |
2007 |
| Alves E, Summavielle T, A... |
Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Ado... |
J Neuroscience |
2007 |
| Chen HI, Kuo YM, Liao CH,... |
Long-term compulsive exercise reduces the rewarding efficacy of 3,4-me... |
Behav Brain Res |
2007 |
| Tilburt JC, Emanuel EJ, K... |
Prescribing 'placebo treatments': results of national survey of US int... |
BMJ |
2008 |
| Halpern JH, Sherwood AR, ... |
Evidence of health and safety in American members of a religion who us... |
Med Sci Monit |
2008 |
| Meyer JS, Piper BJ, Vanco... |
Development and characterization of a novel animal model of intermitte... |
Ann N Y Acad Sci |
2008 |
| Smith Z, Moore K, Measham... |
MDMA powder, pills and crystal: the persistence of ecstasy and the pov... |
Drugs and Alcohol To... |
2009 |
| Allen JW, Gartz J, Sihano... |
The Occurrence, Use and Detection of Psilocine, Psilocybine andBaeocys... |
Ethnomycological J: ... |
2009 |
| Burgess A, Donovan P, Moo... |
Embodying Uncertainty? Understanding heightened risk perception of dri... |
Brit J Criminol |
2009 |
| Biezonski DK, Meyer JS |
Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin trans... |
J Neurochem |
2010 |
